Published in Gene Therapy Weekly, November 4th, 2004
Pharmacogenomics is the science that examines the inherited variations in genes that dictate drug response and explores the way these variations can be used to predict how a patient will respond to a given drug.
PharmaMar launched its pharmacogenomics research program 2 years ago on the basis of data generated from its clinical trials of Yondelis, Aplidin and Kahalalide F. Whereas all three of these drugs have been shown in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.